For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250303:nRSC9832Ya&default-theme=true
RNS Number : 9832Y Centrica PLC 03 March 2025
Centrica plc
3 March 2025
Update on Share Buyback Extension
In its 2024 Preliminary Results on 20 February 2025, the Company announced a
further £500 million extension of the Company's share buyback programme, to
be completed by around the end of 2025 (the "2025 Extension"), taking the
total programme to £2.0bn.
In order to facilitate the 2025 Extension, the non-discretionary agreement
that the Company entered into with Merrill Lynch International ("Merrill
Lynch") to conduct share repurchases on its behalf up to an aggregate
consideration of £270 million (the "2024-25 Extension"), which the Company
announced on 27 December 2024, has been amended so that the period during
which Merrill Lynch will conduct such repurchases will now end no later than
13 June 2025 (instead of 26 September 2025 as previously announced). The
parameters of the 2024-25 Extension otherwise remain as set out in the
announcement on 27 December 2024.
The Company further announces that, following the purchase of shares on 28
February 2025, Goldman Sachs International has concluded its purchase of
shares pursuant to the non-discretionary agreements with the Company announced
on 8 August 2024 and 27 December 2024. Pursuant to these agreements, the
Company has repurchased 181,529,791 ordinary shares in aggregate at an average
execution price of 126.70 pence per ordinary share for a total consideration
(excluding dealing and associated costs) of approximately £229,999,334.
Enquiries:
Investors and Analysts
E: ir@centrica.com
Media
T: 01784 843000
E: media@centrica.com
END
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCZLLFBEXLLBBL